Remove 2019 Remove Individual Remove Patients Remove Provider
article thumbnail

Patient experience with Social Prescribing Program in Ontario, Canada [Social determinants and vulnerable populations]

Annals of Family Medicine

Context Social Prescribing (SP) is an approach to help individuals address their health and social needs wherein a healthcare practitioner refers patients to non-clinal services in the community. Models of SP vary, and the experience of patients across these models is less known. ARC: All (N=17) participants used navigation.

Patients 130
article thumbnail

Differences in primary care utilization by primary care availability in the first year of Virginia Medicaid Expansion [Health care disparities]

Annals of Family Medicine

Importantly, Virginia's Medicaid expansion reduced cost-related barriers to accessing care for over 700,000 individuals. Setting or Dataset: 2019-2020 Virginia Department of Medical Assistance Services database (demographic, enrollment, and claims data). Of these, 117,481 (57.2%) individuals had at least one primary care visit.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Positive Impact of Direct Primary Care on Employer Healthcare Spending

Plum Health

Studies conducted by the Society of Actuaries (SOA) and Milliman provide valuable insights into these new models of healthcare delivery and financing. DPC and Subscription-based Primary Care are healthcare delivery models where a provider offers unlimited specified routine healthcare services for a monthly fee. As of 2019, 49.6%

article thumbnail

Episode 282: Anti-Racism in Medicine Series – Episode 20 – Medical Racism and Indigenous Peoples

The Clinical Problem Solvers

The dehumanization of individuals of color at the margins of society by the healthcare system is not simply a thing of the past, and is certainly a persistent phenomenon. Cindy Gladue, Brian Sinclair, and Joyce Echaquan are three Indigenous individuals who suffered immense harm at the hands of the healthcare system.

Medical 52
article thumbnail

Let’s Listen to Patients: FDA Releases Final Guidance on Patient Engagement in the Design and Conduct of Medical Device Clinical Studies

FDA Law Blog

Bauer, Senior Regulatory Drug Expert — Our readers probably know that we value and advocate for patient engagement as an essential component in the development of medical products (see our firm’s commitment here ).

article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

A multilayered view of stigmatizing discourses lays the foundation for eliciting a series of suggestions for quelling stigma, to be implemented at the individual, community, and national levels, as suggested by the WHO. Psychological health during the coronavirus disease 2019 pandemic outbreak. Scholars such as Wen et al.

article thumbnail

Long-Awaited Guidance on FDAMA 115: Confirmatory Evidence Finally Has Its Moment (to be Crossed Off the FDA’s Guidance To-Do List)

FDA Law Blog

A brief explainer on confirmatory evidence: how we got here Before we dive into the specifics of the new guidance, we should explain that the statutory standard we allude to is the requirement that an applicant provide “substantial evidence of effectiveness” to obtain approval of an NDA or BLA.

IT 64